CG Oncology (CGON) Accumulated Depreciation (2024 - 2026)

CG Oncology's Accumulated Depreciation history runs 3 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• Quarterly Accumulated Depreciation changed N/A year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (changed N/A YoY) and the FY2025 annual result came in at $1.5 million, up 1594.25% from the prior year.
• Accumulated Depreciation was $2.3 million for Q1 2026 at CG Oncology, up from $1.5 million in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $2.3 million in Q1 2026 and bottomed at $87000.0 in Q4 2024.
• A 3-year average of $1.1 million and a median of $1.0 million in 2025 frame the typical range for Accumulated Depreciation.
• Peak annual rise in Accumulated Depreciation reached 1594.25% in 2025, while the deepest fall reached 1594.25% in 2025.
• CG Oncology's Accumulated Depreciation stood at $87000.0 in 2024, then surged by 1594.25% to $1.5 million in 2025, then soared by 55.63% to $2.3 million in 2026.
• Business Quant data shows CGON's Accumulated Depreciation at $2.3 million in Q1 2026, $1.5 million in Q4 2025, and $623000.0 in Q3 2025.